This study will evaluate the safety and immune response to GlaxoSmithKline Tdap vaccine compared to licensed Td vaccine when used as a booster in healthy adolescents (10-18 years of age).
A combined Tdap (Tetanus, Diphteria, Acellular Pertussis) Vaccine Used as a Booster compared to Licensed Td (Tetanus and Diphteria) vaccine
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
4,116
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
GSK Investigational Site
Mesa, Arizona, United States
GSK Investigational Site
Tempe, Arizona, United States
GSK Investigational Site
Jonesboro, Arkansas, United States
GSK Investigational Site
Little Rock, Arkansas, United States
GSK Investigational Site
Escondido, California, United States
GSK Investigational Site
Fullerton, California, United States
GSK Investigational Site
Redondo Beach, California, United States
GSK Investigational Site
Rolling Hills Est, California, United States
GSK Investigational Site
Torrance, California, United States
GSK Investigational Site
Yorba Linda, California, United States
...and 34 more locations